Validation of Quantitative PCR Assays?Addressing Virus Contamination Concerns

Lovatt,Archie;Iain Doherty;Donna McMutrie;John Black;

Publication

Article

March 15, 2002

BioPharm International

BioPharm International-03-15-2002

Volume15

Issue 3

Validation of Quantitative PCR Assays?Addressing Virus Contamination Concerns

Author(s):

Archie Lovatt, PhD,Iain Doherty

by Archie Lovatt, Donna McMutrie, John Black, and Iain Doherty Q-One Biotech Ltd. Real-time quantitative PCR has revolutionized the detection and quantification of viral contaminants. Quantitative PCR assays can detect noncytopathic viruses that have recently become a concern in testing for biopharmaceutical safety. High versatility reproducibility, and throughput of such assays decrease the time spent in development, testing, and regulatory compliance.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?

Guest Editorial: Warning Letters ? A Symptom?

The Importance of Freezing on Lyophilization Cycle Development

Outsourcing Outlook: Using Earned-Value Analysis for Better Project Management

Business Benefits of Computer Systems Validation

Validation of Quantitative PCR Assays?Addressing Virus Contamination Concerns

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!